NIH-funded research NIH-funded research

Investigating cancer causes and early detection markers for prostate, lung, colorectal, and ovarian cancers

Official title: PROSTATE LUNG COLORECTAL OVARIAN (PLCO) ETIOLOGIC AND EARLY MARKER STUDIES (EEMS)

Funded at Information Management Services, INC. · NIH-11115521 · Data updated 2026-11-12

This study is looking for people to help us learn more about what causes prostate, lung, colorectal, and ovarian cancers by sharing samples and information about their health, so we can find better ways to detect and prevent these cancers early on.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionInformation Management Services, INC.
NIH-funded
Lab location1 site (Calverton, United States)
Project startJuly 20, 2022
Project endJuly 19, 2025
Funding year2024
Award (this year)$1,193,091
NIH project number75N91021D00017-P00002-759102200002-1
Project IDNIH-11115521 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals at risk for prostate, lung, colorectal, or ovarian cancers, as well as those who are willing to provide biological samples.

Less likely to help

Patients who do not have a family history or risk factors for the specified cancers may not receive direct benefits from this research.

What this research studies

This research focuses on understanding the causes of prostate, lung, colorectal, and ovarian cancers by collecting biological samples and risk factor information from participants. The study utilizes a large biorepository containing nearly 2.9 million specimens, which will be analyzed to identify early detection biomarkers and improve cancer prevention strategies. Participants will contribute valuable data that can help researchers uncover links between various factors and cancer development, ultimately aiming to enhance early diagnosis and treatment options.

Why it matters

Potential benefit: If successful, this research could lead to improved early detection methods and preventive strategies for several types of cancer.

How similar studies have gone: Previous research has shown success in identifying cancer biomarkers through similar biorepository approaches, indicating a promising avenue for this study.

Where this research is happening

  • Information Management Services, INC.
    Calverton, United States
    Active

Researchers

  • Principal investigator: Riley, Thomas — Information Management Services, INC.
  • Study coordinator: Riley, Thomas

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.